Körber’s Digital Consulting towards Pharma 4.0

Pharma 4.0™ is a concept coined and trademarked by the International Society for Pharmaceutical Engineering (ISPE) to describe the application of the Industry 4.0 ‘Smart Factory’ vision to the specific needs of the pharmaceutical and medical device sectors.

As the ISPE explains, Pharma 4.0 is more of an evolution than a revolution, where digitalization and automation are gradually implemented and adapted to handle the complex and diverse product portfolios and cycles of these industries.

Therefore, Körber’s Digital Consulting services for the pharmaceutical industry do not propose unrealistic or overly ambitious ‘moonshot’ goals, but rather a systematic and incremental approach. Each step is justified by a solid business case and a clear return on investment (ROI) to ensure quick wins.

Assessing Digital Maturity

The Pharma Consultants at Körber follow a dual-track approach to assist clients in developing and executing the digital strategy that best fits the needs of their management, customers, markets, and regulators.

The first step is to evaluate the digital maturity level of the client using a vendor-neutral scoring model developed by partner Biophorum.

The Digital Plant Maturity Model (DPMM) is based on a resource portal that provides the tools needed to assess the readiness and suitability of Pharma 4.0. The consultants are thus able to address the challenging questions that are unique to the life sciences enterprises, such as:

• How the ‘digital plant’ concept can be applied to biopharmaceutical manufacturing
• How to implement the ‘digital plant’ concept to biopharmaceutical manufacturing
• How to define, measure and transform digital plant capabilities
• The level of digital maturity of each facility
• Comparison with industry benchmarks
• Short, medium, and long-term digitalization goals

This assessment examines up to 186 test points in eight relevant dimensions such as “people & culture” and “production planning & supply chain”. Clients can get a thorough overview of how their company compares with industry benchmarks. Körber’s pharma consultants also provide a comprehensive digital maturity assessment, which serves as a basis for the next stage in their journey.

Digital transformation roadmap

With the assessment of the client’s digital maturity as the starting point, the pharma consultants then support the creation of an individual digital transformation roadmap. This roadmap is defined by a series of milestones that follow the specific components of Pharma 4.0 and offer measurable value and ROI.

Körber can guide clients through all stages of their digital transformation: from identifying quick wins with high ROI potential to providing continuous strategic consulting to help companies fully transition to Pharma 4.0.

Their Pharma Consulting expert teams act as personal partners for pharma companies to overcome the complex challenges they face in optimizing and digitalizing their processes in compliance with the latest regulations. These teams have one of the most proven track records in digital transformation in the industry. From the early 2000s, Körber has established itself in this field with a broad range of solutions tailored to the needs of pharmaceutical and biotechnology producers.

The pharma consultants of Körber are specialists in addressing the specific inquiries related to the production in these highly regulated industries. This expertise enables them to identify solutions that exactly match individual needs.

Resources

Click on Digital Consulting: Pharma 4.0 tailor-made to your needs for more information.
Click on Your Digital Maturity: Assessment and Strategy to download brochure (sign up/login required).